| Financial Year |
March 31 2023 |
| Monetary Funds |
2,232,754,457.25 |
| Held-for-trading Financial Assets |
43,653,468.12 |
| Notes Receivable |
545,185,380.17 |
| Accounts Receivable |
6,506,538,544.43 |
| Advances to Suppliers |
300,245,067.09 |
| Other Receivables |
447,958,180.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,916,869,104.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,763,727.00 |
| Other Current Assets |
482,573,407.21 |
| Total Current Assets |
13,742,045,101.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
21,032,305.60 |
| Long-term Equity Investment |
1,610,251,056.39 |
| Investment Properties |
23,641,330.72 |
| Fixed Assetes |
3,151,418,006.79 |
| Under-construction Projects |
482,740,644.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
856,570,278.41 |
| R&D expenses |
-- |
| Goodwill |
189,285,536.47 |
| Long-Term Deferred and Prepaid Expenses |
11,775,760.27 |
| Deferred Income Tax Assets |
604,091,341.49 |
| Other Non-Current Assets |
55,996,502.54 |
| Sub-Total of Non-Current Assets |
7,879,256,772.29 |
| Total Assets |
21,621,301,873.88 |
| Short-Term Loans |
2,591,776,608.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,927,152,039.00 |
| Accounts Payable |
4,604,818,541.04 |
| Accounts Received In Advance |
20,168,110.46 |
| Employee Compensation Payable |
94,502,492.71 |
| Taxes Payable |
124,236,764.51 |
| Interest Payable |
-- |
| Dividend Payable |
216,287.12 |
| Other payables |
480,783,624.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
557,045,469.85 |
| Other Current Liabilities |
384,003,492.50 |
| Sub-Total of Current Liabilities |
11,542,925,967.78 |
| Long-term Loans |
1,494,578,652.93 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,115,274.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
24,891,022.25 |
| Deferred Income Tax Liabilities |
69,070,986.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,831,428,593.41 |
| Total Liabilities |
14,374,354,561.19 |
| Paid-In Capital(Or Share Stock) |
1,040,710,713.00 |
| Capital Surplus |
3,301,018,193.93 |
| Surplus Reserve |
176,682,885.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,790,876,040.79 |
| Minority Stockholder's Interest |
925,341,278.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,321,606,034.69 |
| Owner's Equity（Stockholder's Equity） |
7,246,947,312.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,621,301,873.88 |
